abstract |
The present invention refers to the use of 5HT7 receptor agonists for the treatment of the symptoms of pain, especially certain subtypes of pain like neuropathic pain, the prevention or the prophylaxis of the symptoms of pain, like neuropathic pain, especially certain subtypes of neuropathic pain or allodynia. |